Moraiya

Rediff.com » News » Moraiya

News for Moraiya

Business

US drug shortage a shot in the arm for Indian pharmaceutical companies

Drug shortages in the US are at an all-time high, and price erosion has stabilised, which could benefit Indian pharmaceutical (pharma) companies with a US focus, according to analysts. Image used......

Why Zydus is likely to continue with its outperformance

Even as most of its large-cap pharmaceutical peers have struggled to stay above water on the returns front, Zydus Lifesciences has been one of the big outperformers within the sector over the past......

Can these stocks shine amid market gloom?

Investors turn their attention to export-driven sectors, experts tell Krishna Kant. Illustration: Uttam Ghosh After betting on the domestic consumption story for over three years, equity investors......

Markets make handsome gains on December F&O expiry

Markets scaled higher on the last day of December derivatives series due to strength in energy and index heavyweight shares such as HDFC and Infosys. The S&P BSE Sensex ended higher 158 points at......

USFDA raises concern over drug production process at Cadila

Sources say FDA letter over product and not entire facilityThe US Food and Drug Administration (FDA) has expressed concerns over the manufacturing process of at least one product at drugmaker......

Rediff News

Moraiya

News for Moraiya

US drug shortage a shot in the arm for Indian pharmaceutical companies

Why Zydus is likely to continue with its outperformance

Can these stocks shine amid market gloom?

Markets make handsome gains on December F&O expiry

USFDA raises concern over drug production process at Cadila

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS